Box 34
Container
Contains 14 Results:
Advisory Committee on Investigational Drugs: correspondence, 1963-1965
File — Box: 34, Folder: 13
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1963-1965
Advisory Committee on Investigational Drugs: papers and background materials, 1963-1965
File — Box: 34, Folder: 14
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1963-1965
FDA: general, 1963-1987
File — Box: 34, Folder: 8
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1963-1987
FDA regulations and guidelines, 1967-1974
File — Box: 34, Folder: 9
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1967-1974